Esperion Therapeutics Inc. Common Stock is a biopharmaceutical company that specializes in the research and development of innovative therapies for the treatment of cardiovascular and metabolic diseases. With a focus on developing cost-effective and patient-centric solutions, Esperion is dedicated to improving the lives of millions around the world.
Notification